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ABSTRACT
Aim: To identify whether pulse oximetry technology is associated with decreased
retinopathy of prematurity (ROP) and laser treatment.
Methods: Inborn infants <1250 g who had eye exams were compared at two cen-
tres in three periods. In Period 1, SpO2 target was ‡93% and pulse oximetry technology
was the same in both Centres. In Period 2, guidelines for SpO2 88–93% were imple-
mented at both centres and Centre B changed to oximeters with signal extraction technol-
ogy (SET
 ) while Centre A did not, but did so in Period 3. One ophthalmology department
performed eye exams using international criteria.
Results: In 571 newborns <1250 g, birth weight and gestational age were similar in
the different periods and centres. At Centre A, severe ROP and need for laser remained the
same in Periods 1 and 2, decreasing in Period 3–6% and 3%, respectively. At Centre B,
severe ROP decreased from 12% (Period 1) to 5% (Period 2) and need for laser
decreased from 5% to 3%, remaining low in Period 3.
Conclusion: In a large group of inborn infants <1250 g, a change in clinical practice in
combination with pulse oximetry with Masimo SET, but not without it, led to signiﬁcant reduction in
severe ROP and need for laser therapy. Pulse oximetry selection is important in managing critically
ill infants.
INTRODUCTION
Retinopathy of prematurity (ROP) is a devastating and com-
mon blinding disease in developed and developing countries
(1,2). However, most cases of ROP are mild and regress
spontaneously. The incidence of this disease has been
reported to be as high as 29% in very low birth weight infants
(VLBW) and is strongly associated with smaller and sicker
infants (3–5). There are many risk factors involved in the
pathogenesis of ROP (5–8), and two phases of abnormal ves-
sel development have been described in ROP. Phase I is
characterized by delayed retinal vascular growth and partial
regression of existing vessels. Phase II is characterized by
pathological vessel growth associated with hypoxia (2). The
use of oxygen and ﬂuctuations of arterial oxygen are consid-
ered major risk factors for the development severe ROP in
preterm infants. (2,6,8). We and others have shown that
lower saturation targets are associated with improved rates
of ROP (9–14) and that there is a treatment-by-gender effect
when aiming to avoid hyperoxia in preterm infants in the
Neonatal Intensive Care Unit (NICU) (15). Strategies to
lower the incidence of ROP include the following: education
and commitment of bedside care providers, guidelines to
decrease hyperoxemic periods and wide changes in oxygen-
ation and the advances in saturation monitoring technology.
The impact of each of these interventions on the incidence
of ROP is not easy to discriminate. In the last decade, it has
become clear that performance of pulse oximeters differ by
brand, with some brands having a much higher incidence of
false alarms and holding periods and reduced reliability (16–
21). Of the next generation pulse oximetry technologies,
only one has signal extraction technology (SET), which has
been shown to have fewer false alarms and missed events in
challenging clinical situations such as during motion and
low perfusion. (22–26). However, no studies have explored
the role that SpO2 technology plays in the prevention or
ROP. We designed this study to determine whether the inci-
dence of severe ROP is associated with the type pulse oxime-
try technology utilized in the NICU, when oxygen saturation
limits are aimed to be maintained between 88 and 93% after
education and guidelines are implemented. Our hypothesis
was that the relative risk reduction in severe retinopathy of
prematurity is associated with the saturation technology
utilized in neonatal intensive care units.
PATIENTS AND METHODS
After Internal Review Board approval, this observational
descriptive study was conducted in two centres at Emory
Acta Pædiatrica ISSN 0803–5253
188 ª2010 The Author(s)/Acta Pædiatrica ª2010 Foundation Acta Pædiatrica 2011 100, pp. 188–192University during two consecutive 3 -year periods (Periods
1 and 2) and an 18- month follow-up period (Period 3).
Centre A was Grady Memorial Hospital, and Centre B was
Emory Crawford Long Hospital. Table 1 shows a schematic
representation of the study design. Inborn infants, with birth
weight <1250 g that had detailed ROP examinations by an
ophthalmologist from Emory University following AAP and
AAO guidelines (27), were included in this study. The exclu-
sion criteria were as follows: newborns with major congeni-
tal anomalies, outborn infants, infants with birth weight
‡1250 g and those who had no ophthalmologic examina-
tion.
During the ﬁrst period, oxygen saturation targets were
between 92% and 100%, and the pulse oximeters used at
both centres were Nellcor N-300 and Nellcor N-395, (Nell-
cor
 , Covidien, Boulder, CO, USA). As part of an intense
quality improvement effort, an educational process was ini-
tiated for oxygen utilization and monitoring in the two cen-
tres. This led to guideline development and implementation,
as described previously (9,10). In Period 2, the new practice
guidelines for lower oxygen saturation targets of 88–93% for
premature infants receiving supplemental oxygen were
implemented at both centres (Table 1). During Period 2, the
pulse oximeters were changed to Masimo SET
  (Masimo,
Irvine, CA, USA) in Centre B while Centre A continued to
use the Nellcor
  technology. During Period 3, both centres
continued to practise the guidelines for oxygen saturation
targets and Centre A changed to pulse oximetry with SET so
that both centres were using SET technology. During all
three periods, the medical leadership, attending neonatolo-
gists, neonatal fellows and neonatal nurse practitioners
were the same in both centres and followed the same guide-
lines for the care of neonates (Table 1). Of course, other
improvements other than oxygen management did occur
over the study period, but they affected at all infants regard-
less of the type of monitoring used.
Data analyses and statistics
In both centres, the data were collected prospectively and
entered into a single, combined database by the same per-
sonnel for subsequent analysis. The data for all infants in
both centres were also reported to Vermont Oxford
Network (VON). Statistics included chi square, Student’s t-
test and ANOVA when appropriate. Only infants with
detailed ROP examinations were used in the denominator
to calculate the incidence of severe ROP and need for laser
therapy in all periods and centres. All the statistical analyses
were carried out using the same software (SPSS version
15.0 for Windows; SPSS, Chicago, IL, USA).
RESULTS
During the three study periods, there were 774 newborns
with BW <1250 g admitted to the study centres. Of them,
571 had eye exams and met all the inclusion criteria. From
Centre A, there were 138 infants included during Period 1,
113 during Period 2 and 65 during Period 3. From Centre B,
there were 83 infants included in Period 3, 115 infants in
Period 2 and 57 in Period 3. There were no signiﬁcant dif-
ferences in patient characteristics between the two centres.
Table 2 summarizes some of the characteristics of the
patient population. During the three study periods, we did
not identify any child who suffered from stage V ROP in
either of the centres.
The rate of ROP III and IV and laser treatment in exam-
ined infants with birth weight <1250 g in Centre B were
12% and 5% in Period 1 and signiﬁcantly decreased to 5%
and 3% in Period 2 following the change to SET technology
(p < 0.05) (Table 3). Based on this decrease in the incidence
of severe ROP in Centre B, the relative risk reduction can
be calculated at 58%, with a number needed to treat of 14.
In Centre B, the incidence remained low in Period 3, 4%
and 2%, respectively. In Centre A in Period 1, ROP III–IV
and laser rates were 13% and 4.5%, respectively, and did
not decrease in Period 2. In Period 3, following the change
to SET technology, ROP III–IV decreased to 6% with a rela-
tive risk reduction of 54% (p < 0.05), and laser rates
decreased to 3%.
We also examined the individual incidence of severe
ROP for each of the years of Periods 1 and 2 at each centre.
As expected, there was variability between each year. At
Centre A, the incidence of ROP III–IV varied between 15%
and 10% during the years of Period 1 and was relatively sta-
ble with an average of 13% per year during Period 2 while
the technology was not changed. Similarly, at Centre B, the
incidence of severe ROP varied during the years of Period 1
(10–13%). Unlike Centre A, severe ROP decreased each
year during Period 2, starting at 10% in the ﬁrst year and
decreasing to 3% in the last year of the period, The rates of
laser surgery treatment for severe ROP in Centre A
decreased during Period 3 while at Centre B the rates
decreased during Period 2 and remained as low during Per-
iod 3. With ‘lower’ oxygen saturation targets of 88–93%, the
mortality was similar and there was no increase in periven-
tricular leucomalacia; the rate of bronchopulmonary displa-
sia was improved, and the incidence of necrotizing
enterocolitis and patent ductus arteriosus did not increase.
Additionally, the longer term outcome was better in the
period with lower targets in the infants available for follow
up (10).
Table 1 Schematic description of the study design
Period I
3 years
2001–2003
Period II
3 years
2004–2006
Period III
18 months
2007–2008
SpO2 Range SpO2 ‡ 92% SpO2 88–93% SpO2 88–93%
Pulse Oximetry
Type
Centres A and
B: Nellcor
 
Centre A: Nellcor
 
Centre B:
Masimo SET
Centres A and
B: Masimo SET
 
Practice
Intervention
None Educational process, guidelines develop-
ment and implementation
Practitioners
and data
Leadership and health care team members: same (but for
RN’s and RRT’s; see text). Data from the two centres col-
lected prospectively into same data base
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This study conﬁrms that while ROP is a potentially serious
condition, it can be reduced in at risk newborns. The ﬁnd-
ings of this study show a signiﬁcant decrease in the inci-
dence of severe ROP and need for laser surgery during the
period after education and practice changes when SET
pulse oximetry technology was used. Furthermore, the
lower incidence of ROP following the practice changes and
change in pulse oximetry was progressively more signiﬁcant
year after year. In this study of 571 infants, none was
blinded by stage V ROP and only about £5% needed treat-
ment to prevent blindness.
Among the most important ROP, prevention efforts are to
decrease wide changes in oxygenation and hyperoxemic
periods (9–16,28). At the two centres studied, the same
intense educational process and clinical guidelines aimed to
decrease hyperoxemia, and wide changes in oxygenation
were implemented. In 1992, Flynn et al. were the ﬁrst to
describe an association between the incidence and severity
of retinopathy of prematurity and the duration of exposure
to arterial oxygen levels of 80 mmHg or higher, measured
transcutaneously (29). As we have shown that saturations
>94% are likely to be associated with PaO2 > 80 mmHg in
infants breathing supplemental oxygen (30), the target val-
ues were to avoid those levels of saturation. The leadership,
physicians and nurse practitioners were the same at both
centres during the three study periods. The pulse oximetry
technology changed to SET technology at one centre after
Period 1 and stayed the same at the other centre but then
was changed at the second centre during Period 3. The ﬁnd-
ings of this study show a strong positive association between
the use of pulse oximetry with SET and a reduction in the
incidence of ROP.
Many factors contribute to good medical care and out-
come improvement. Among them are education, training,
commitment, team work, eradicating bad practices, and
the correct use of the best available technology. In general,
it is well accepted in most areas of medical care that tech-
nology by itself, without education and appropriate use,
serves very little value for care improvement. On the other
hand, well-trained committed clinicians obtain worse out-
comes when using technology that is obsolete, outdated or
of lesser quality. The ﬁndings clearly suggests that, when
all other interventions are the same, an educational pro-
cess and improved care guidelines along with a change to
improved pulse oximetry technology are useful for reduc-
ing the incidence of severe neonatal ROP and need for
laser surgery.
In contrast to the interventional devices and therapies,
there is a tendency by some clinicians to believe that non-
therapeutic monitoring devices with similar functionality
deliver similar performance. However, as clinicians, we all
understand that the decisions we make, right or wrong, are
often based on the numbers shown on patient monitors.
Therefore, the accuracy and reliability of monitored physio-
logic information can be just as important, if not more
important, than the therapeutic interventions that follow. In
this study, we have shown that use of one type of pulse
oximetry technology appears to strongly affect the incidence
of ROP.
We acknowledge that there are some limitations in this
study. This was not a randomized controlled trial, so the
results cannot deﬁnitively isolate the pulse oximetry tech-
nology as the major only factor contributing to decreasing
incidence of ROP. However, it is unlikely that such a study
could ever be performed in a randomized way. In addition,
while the physicians and nurse practitioners were the same
at both centres, the bedside nurses and respiratory thera-
pists were different. As the rates of severe ROP were signiﬁ-
cantly lower at Centre B compared to Centre A in period 2
(Table 3) in association with implementation of SET tech-
nology and a reduction in severe ROP and need for laser
surgery occurred in Centre A in Period 3, when change of
technology occurred, it is unlikely that bedside nurses and
respiratory therapists played a major role in the different
outcomes during the different periods. Nonetheless, the sig-
niﬁcance or ‘weight’ of different bedside health care provid-
ers cannot be separately discriminated in this study.
Finally, a very recent article reports markedly decrease
ROP but worse mortality when saturation targets are
Table 2 Demographics of the studied population
Centres Period (n)
AB
Period 1 (138) Period 2 (113) Period 3 (65) Period 1 (83) Period 2 (115) Period 3 (57)
Gestational weeks 27 ± 2 27 ± 2.3 27 ± 1.6 26.8 ± 2.1 26.8 ± 2.2 27 ± 2.4
Birth Weight (g) 922.8 ± 190 914 ± 208 907 ± 183 889.6 ± 203 866 ± 198 897 ± 206
Antenatal Steroids 78% 79% 80% 64% 77% 81%
Female 56% 51% 53% 55% 53% 52%
Mechanical Ventilation 92% 83% 86% 85% 81% 83%
Small for gestation 21% 21% 20% 21% 23% 21%
No signiﬁcant statistical signiﬁcance was identiﬁed for any variable.
Table 3 Rates of retinopathy of prematurity (ROP) and laser surgery for each
centre in each period in examined infants <1250 g
Centre A Centre B
Period 1 Period 2 Period 3 Period 1 Period 2 Period 3
ROP III–IV 13% 13%**
,† 6%
† 12%
¶ 5%**
,¶ 4%
LASER 4.5% 5% 3% 5%* 3%* 2%
All comparisons (†;**; ¶; *): p < 0.05.
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studies published to date, no one has aimed for a target of
85–89%. Therefore, we cannot compare or comment on
those ﬁndings. Further data are waited from other large
ongoing randomized clinical trials.
CONCLUSIONS
In this study of inborn infants with birth weight <1250 g
treated by the same physicians and nurse practitioners using
the same clinical guidelines aimed at decreasing hyperox-
emia and wide changes in oxygenation, a reduction in the
incidence of severe ROP and need for laser therapy were
associated with the use of signal extraction pulse oximetry.
The ﬁndings lend further support to the signiﬁcance of using
improved saturation monitors in managing critically ill
infants. Education, guidelines and practice changes for
reducing ROP may be more effective when accurate and
reliable pulse oximetry technology is used.
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